Sanabria FS, Lara VHP

Idioma: Español
Referencias bibliográficas: 22
Paginas: 213-217
Archivo PDF: 416.55 Kb.

RESUMEN

El Síndrome Urémico Hemolítico afecta principalmente a pacientes en edad pediátrica. Se caracteriza por la triada de anemia hemolítica microangiopática, trombocitopenia e insuficiencia renal aguda. El SUH es la principal causa de fallo renal agudo en niños. Se conocen diferentes tipos y agentes causales de SUH que es importante distinguir pues los cursos clínicos y pronósticos de cada una son diferentes.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Atkinson J, Goodship T. Complement factor H and the hemolytic uremic syndrome. JEM 2007; 204: 1245–1248

2. Berger S, Daha M. Complement in glomerular injury. Semin Immunopathology 2007; 29: 375–384

3. Beutin L et al. Evaluation of Major Types of Shiga Toxin 2e-Producing Escherichia coli Bacteria Present in Food, Pigs, and the Environment as Potential Pathogens for Humans. Applied and environmental microbiology 2008;74 (15): 4806–4816

4. Bielaszewska M et al. Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm? PLoS ONE 2(10): e1024. doi:10.1371/journal.pone.0001024

5. Cicuta, M. Detección de Escherichia coli productor de toxina Shiga en reses bovinas y carne molida de Corrientes, Argentina. Rev. vet. 2006: 17: 1, 20–25

6. Davin J et al. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatric Nephrology 2008; 23:1517–1521

7. Fàbregas A, et al. Enfermedad neumocócica invasiva y síndrome hemolítico urémico. An Pediatr (Barc). 2008;68(3):269-272

8. Kejariwal D. Cholelithiasis associated with haemolytic-uraemic syndrome. World Journal Gastroenteroly 2006; 12(14): 2291-2292

9. Leotta G et al. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiology 2008; 8(46): 1-8

10. Medellin-Peña M, et al. Probiotics Affect Virulence-Related Gene Expression in Escherichia coli O157:H7. Applied and environmental microbiology 2007; 73 (13): 4259–4267

11. Mellmann A. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli. Emerging Infectious Diseases 2008; 14(8): 1287-1290

12. Pérez del Campo Y et al. Síndrome Hemolítico Urémico: aspectos epidemiolódgicos y patogénicos. Rev Cubana Pediatr 2000;72(3):203-13

13. Pistone V et al. Papel de la toxina Shiga en el Síndrome Urémico Hemolítico. MEDICINA (Buenos Aires) 2006; 66 (3): 11-15

14. Pistone V et al. Efecto cititóxico de la toxina Shiga tipo 2 y su subunidad B en células epiteliales tubulares renales humanas en cultivo. MEDICINA (Buenos Aires) 2005; 65: 147-150

15. Pradel N et al. Molecular Analysis of Shiga Toxin-Producing Escherichia coli Strains Isolated from Hemolytic-Uremic Syndrome Patients and Dairy Samples in France. APPLIED AND ENVIRONMENTAL MICROBIOLOGY 2008; 74 (7): 2118–2128

16. Rivas M, et al. Risk Factors for Sporadic Shiga Toxin–producing Escherichia coli Infections in Children, Argentina. Emerging Infectious Diseases 2008; 14(5): 763-771

17. Schimmer B et al. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infectious Diseases 2008; 8(41): 1-10

18. Sinha A, Rai R. Haemolytic Uraemic Syndrome Following Acute Pancreatitis. Journal of Pancreas 2005; 6(4):365-368.

19. Sorrell D. Hemolytic Uremic Syndrome. Oncology Nursing Forum 2008;35 (4); 593-596

20. Taylor M. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatric Nephrology 2008; 23:1425–1431

21. Venables J et al. Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene. PLoS Med 2006; 3 (10): e431. DOI: 10.1371/journal. pmed.0030431

22. Zheng L, Sadler J. Pathogenesis of Thrombotic Microangiopathies. Annu Rev Pathol. 2008; 3: 249–277